Related Experiment Video
Updated: May 3, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Presynaptic enzymatic neurotoxins
Ornella Rossetto1, Laura Morbiato, Paola Caccin
1Dipartimento di Scienze Biomediche and Istituto CNR di Neuroscienze, Università di Padova, Padova, Italy. ornella.rossetto@unipd.it
Abstract:
Botulinum neurotoxins produced by anaerobic bacteria of the genus Clostridium are the most toxic proteins known, with mouse LD50 values in the 1-5 ng/kg range, and are solely responsible for the pathophysiology of botulism. These metalloproteinases enter peripheral cholinergic nerve terminals and cleave proteins of the neuroexocytosis apparatus, causing a persistent, but reversible, inhibition of neurotransmitter release. They are used in the therapy of many human syndromes caused by hyperactive nerve terminals. Snake presynaptic PLA2 neurotoxins block nerve terminals by binding to the nerve membrane and catalyzing phospholipid hydrolysis with production of lysophospholipids and fatty acids. These compounds change the membrane conformation, causing enhanced fusion of synaptic vesicle via hemifusion intermediate with release of neurotransmitter and, at the same time, inhibition of vesicle fission and recycling. It is possible to envisage clinical applications of the lysophospholipid/fatty acid mixture to inhibit hyperactive superficial nerve terminals.
Insights
Botulinum neurotoxins and snake venom toxins inhibit nerve function by targeting nerve terminals. These toxins offer potential therapeutic applications for managing hyperactive nerve conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Toxicology
Background:
- Botulinum neurotoxins (BoNTs), highly toxic proteins from Clostridium, cause botulism by cleaving neuroexocytosis proteins in nerve terminals, inhibiting neurotransmitter release.
- These neurotoxins are therapeutically used for conditions involving hyperactive nerve terminals.
- Snake presynaptic phospholipase A2 (PLA2) neurotoxins disrupt nerve terminal function by hydrolyzing phospholipids, altering membrane dynamics and neurotransmitter release.
Purpose of the Study:
- To elucidate the mechanisms of action of botulinum neurotoxins and snake presynaptic PLA2 neurotoxins.
- To explore the potential therapeutic applications of these neurotoxins and their byproducts.
Main Methods:
- Analysis of the molecular mechanisms by which BoNTs inhibit neurotransmitter release.
- Investigation of the effects of snake PLA2 neurotoxins on nerve terminal membrane structure and function.
- Examination of phospholipid hydrolysis products (lysophospholipids and fatty acids) generated by PLA2.
Main Results:
- Botulinum neurotoxins act as metalloproteinases, cleaving key proteins in the neuroexocytosis pathway.
- Snake PLA2 neurotoxins induce both neurotransmitter release and subsequent inhibition of vesicle recycling through membrane alteration.
- Lysophospholipids and fatty acids produced by PLA2 activity were identified as key mediators of these effects.
Conclusions:
- Botulinum neurotoxins provide a model for understanding and treating conditions with excessive nerve activity.
- Snake venom PLA2 neurotoxins offer insights into synaptic vesicle dynamics and neurotransmission.
- The lysophospholipid/fatty acid mixture generated by PLA2 has potential for therapeutic use in inhibiting superficial hyperactive nerve terminals.
More Related Videos
Related Concept Videos
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Neurochemical Transmission: Sites of Drug Action
Cholinergic Neurons: Neurotransmission
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Drugs Affecting Neurotransmitter Synthesis

